About: http://data.cimple.eu/news-article/9bd2e5c6403580e6260fbdd0fcd3ee254e870c36d6c4685f4fb62353     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • An Australian court upheld a landmark class-action lawsuit against Johnson & Johnson for "negligent" marketing of pelvic mesh implants on Friday, paving the way for thousands of women to receive compensation in a costly setback for the US pharma giant. Johnson & Johnson had appealed the 2019 ruling that found the company guilty of "negligent" marketing and "deceptive conduct" while supplying thousands of pelvic meshes in Australia. Victims said the mesh -- designed to support weakened muscles holding up the pelvic organs -- had caused disastrous side-effects including incontinence, infections and chronic pain. "The risks were known, not insignificant, and on the respondents' own admission, could cause significant and serious harm," the judge said in the initial ruling. A three-judge panel at the federal court dismissed the appeal on Friday, a decision that "confirmed that these women are entitled to be compensated for the losses and the life-altering complications that they have suffered as a result of these implants," said Rebecca Jancasukas, a lawyer for the claimants. Shine Lawyers, which led the class action suit, said it would now vigorously pursue compensation claims possibly amounting to hundreds of millions of dollars. The three women involved in the 2019 suit were awarded compensation ranging from Aus$556,000 to Aus$1.28 million (US$430,000-US$1 million). The remaining members of the class action will now bring their own individual claims to court. Responding to Friday's ruling, Johnson & Johnson said it "empathises with all women who experience medical complications" but would review the court decision and "consider its options". Worldwide, more than two million women have had the mesh products implanted in their bodies and the Australian ruling is just one in a series globally. Early last year, a judge in California ordered Johnson & Johnson to pay $344 million for false and deceptive marketing of pelvic mesh products used by tens of thousands of women in the state. The company has settled similar claims with the state of Washington for $9.9 million and a coalition of 42 other states for $117 million. dm/lb/jfx
schema:headline
  • Australian court upholds landmark suit against Johnson & Johnson
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software